Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly a lift.

Previous Article

Hours After Taylor Lorenz Gushes Over 'Handsome Revolutionary' UNH Killer, Intruder Arrested At HQ

Next Article

Fed’s Waller says interest rates may need to be cut soon if largest Trump tariffs stay in place

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

− 1 = 9
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨